P400: PROTEOGENOMIC CHARACTERIZATION OF 5-AZACYTIDINE EFFECTS ON ACUTE MYELOID LEUKEMIA IMMUNOPEPTIDOME

P400: PROTEOGENOMIC CHARACTERIZATION OF 5-AZACYTIDINE EFFECTS ON ACUTE MYELOID LEUKEMIA IMMUNOPEPTIDOME

Bibliographic Details
Main Authors:	G. Ehx, N. Nandita, C. Durette, J. Courtois, M.-P. Hardy, K. Vincent, J.-P. Laverdure, J. Lanoix, F. Baron, P. Thibault, C. Perreault
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000844488.25409.8e

Similar Items

BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens
by: Maria Virginia Ruiz Cuevas, et al.
Published: (2023-08-01)

145 Proteogenomic approaches for exploring the dark immunopeptidome
by: Daniel Le, et al.
Published: (2023-11-01)

Most non-canonical proteins uniquely populate the proteome or immunopeptidome
by: Maria Virginia Ruiz Cuevas, et al.
Published: (2021-03-01)

Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames
by: Céline M. Laumont, et al.
Published: (2016-01-01)

The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation
by: Etienne Caron, et al.
Published: (2011-09-01)

Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes
by: Chloe Chong, et al.
Published: (2020-03-01)

Transfusion independence and survival in patients with acute myeloid leukemia treated with 5-azacytidine
by: Mathilde Gavillet, et al.
Published: (2012-12-01)

Proteogenomic characterization of highly enriched viable leukemic blasts in acute myeloid leukemia: A SWOG report
by: Jasmine Naru, et al.
Published: (2024-12-01)

AZACYTIDINE (A) ASSOCIATED WITH VITAMINS (B1, C, AND D) IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA.
by: R Conserva, et al.
Published: (2023-10-01)

ACUTE MYELOID LEUKEMIA IN COMPLETE RESPONSE FOR 2 YEARS WITH AZACYTIDINE ASSOCIATED WITH HIGH-DOSE VITAMINS
by: VM Sthel, et al.
Published: (2023-10-01)

The use of 5-azacytidine in pregnant patient with Acute Myeloid Leukemia (AML): a case report
by: Abdullah M. Alrajhi, et al.
Published: (2019-10-01)

P449: PROTEOGENOMIC PROFILING OF DIAGNOSTIC AND RELAPSE SAMPLES IN PEDIATRIC ACUTE MYELOID LEUKEMIA
by: Tina Glisovic-Aplenc, et al.
Published: (2023-08-01)

Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease
by: Gilles Fransolet, et al.
Published: (2016-07-01)

SUMOylation inhibitor TAK-981 (subasumstat) synergizes with 5-azacytidine in preclinical models of acute myeloid leukemia
by: Ludovic Gabellier, et al.
Published: (2023-08-01)

872 Combined multi-omics analysis delineates the impact of epigenetic therapies on the immunopeptidome of acute myeloid leukemia
by: Hans-Georg Rammensee, et al.
Published: (2023-11-01)

Integrated RNAi screening identifies the NEDDylation pathway as a synergistic partner of azacytidine in acute myeloid leukemia
by: Justine Klosner, et al.
Published: (2021-12-01)

Acute myeloid leukemia synchronous with multiple myeloma successfully treated by azacytidine/lenalidomide and daratumumab without a decrease in myeloid clone size
by: Celine Berthon, et al.
Published: (2020-01-01)

Proteogenomics refines the molecular classification of chronic lymphocytic leukemia
by: Sophie A. Herbst, et al.
Published: (2022-10-01)

Implications of MHC-restricted immunopeptidome in transplantation
by: Zhuldyz Zhanzak, et al.
Published: (2024-07-01)

Treatment of Chronic Myelomonocytic Leukemia with 5-Azacytidine: Case Reports
by: Peter Rohon, et al.
Published: (2012-01-01)

Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy
by: Xu N, et al.
Published: (2021-04-01)

Azacytidine Treatment for VEXAS Syndrome
by: Marc H. G. P. Raaijmakers, et al.
Published: (2021-12-01)

The efficacy and safety of venetoclax and azacytidine combination treatment in patients with acute myeloid leukemia and myelodysplastic syndrome: systematic review and meta-analysis
by: Yufeng Du, et al.
Published: (2023-12-01)

5-azacytidine for beta-thalassemia?
by: Clegg, J, et al.
Published: (1983)

5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature
by: Mariangela Greco, et al.
Published: (2011-03-01)

5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature
by: Marianna Criscuolo, et al.
Published: (2011-01-01)

Synthesis and Antiproliferative Activities of 5-Azacytidine Analogues in Human Leukemia Cells
by: Lin-Xiang Zhao, et al.
Published: (2008-07-01)

Comprehensive analysis of m6A methylome alterations after azacytidine plus venetoclax treatment for acute myeloid leukemia by nanopore sequencing
by: Zaifeng Zhang, et al.
Published: (2024-12-01)

Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia
by: Annika Nelde, et al.
Published: (2021-07-01)

Immunopeptidomics special issue
by: Ternette, N, et al.
Published: (2018)

Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies
by: Qingyu Xu, et al.
Published: (2023-03-01)

The Proteogenomic Mapping Tool
by: Dandass Yoginder S, et al.
Published: (2011-04-01)

Transcriptomic Profiles of MV4-11 and Kasumi 1 Acute Myeloid Leukemia Cell Lines Modulated by Epigenetic Modifiers Trichostatin A and 5-Azacytidine
by: Mat Jusoh Siti Asmaa, et al.
Published: (2020-01-01)

Immunopeptidomics in the cancer immunotherapy era
by: Sutatip Pongcharoen, et al.
Published: (2024-07-01)

Immunopeptidomics toolkit library (IPTK): a python-based modular toolbox for analyzing immunopeptidomics data
by: Hesham ElAbd, et al.
Published: (2021-08-01)

Widespread and tissue-specific expression of endogenous retroelements in human somatic tissues
by: Jean-David Larouche, et al.
Published: (2020-04-01)

Integrated Immunopeptidomic and Proteomic Analysis of COVID-19 lung biopsies
by: Shanye Yin, et al.
Published: (2023-10-01)

Our treatment experience with azacytidine in patients with acute myeloid leukaemia, chronic myelomonocytic leukaemia and myelodysplastic syndrome
by: Peter Černelč, et al.
Published: (2012-12-01)

The HLA class-II immunopeptidomes of AAV capsids proteins
by: Carlos A. Brito-Sierra, et al.
Published: (2022-12-01)

The HLA class I immunopeptidomes of AAV capsid proteins
by: Carlos A. Brito-Sierra, et al.
Published: (2023-08-01)